Sexual performance and longevity

Experimental Gerontology

Volumn 32, Issue 4-5, 1997, Pages 539-552

  Knoll, J ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

( )deprenyl; Brain activation; CAE effect; Catecholaminergic activity enhancer (CAE); High performing rat; Learning performance; Longevity; Low performing rat; Prolongation of life; Sexual performance

Indexed keywords

DOPAMINE; NORADRENALIN; SELEGILINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; FEMALE; LIFESPAN; LOCUS CERULEUS; LONGEVITY; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; OLFACTORY NUCLEUS; PRIORITY JOURNAL; RAT; SEXUAL BEHAVIOR; SUBSTANTIA NIGRA;

ANIMALS; BRAIN; CATECHOLAMINES; COPULATION; FEMALE; LEARNING; LONGEVITY; MALE; MONOAMINE OXIDASE INHIBITORS; PHENETHYLAMINES; RATS; RATS, WISTAR; SELEGILINE; SEXUAL BEHAVIOR, ANIMAL; SODIUM CHLORIDE; VEHICLES;

ANIMALIA;

EID: 0030743792     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(96)00157-X     Document Type: Conference Paper

References (16)

1. BIRKMAYER, W., KNOLL, J., RIEDERER P., YOUDIM, M.B.H., HARS, V., and MARTON, J. Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: A longterm study. J. Neural. Transm. 64, 113-127, 1985.
2. KNOLL, J. The Theory of Active Reflexes. An Analysis of Some Fundamental Mechanisms of Higher Nervous Activity, Publishing House of the Hungarian Academy of Sciences, Budapest; Hafner Publishing Company, New York, 1969, p. 131.
3. KNOLL, J. Memories of my 45 years in research. Pharmacol. Toxicol. 75, 65-72, 1994.
4. KNOLL, J. Rationale for (-)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes. Biomed. Pharmacother. 49, 187-195, 1995.
5. KNOLL, J. and MIKLYA, I. Multiple, small dose administration of (-)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition. Arch. Int. Pharmacodyn. Ther. 328, 1-15, 1994.
6. KNOLL, J. and MIKLYA, I. Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: Rationale for prophylactic (-)deprenyl (selegiline) medication. Life Sci. 56, 611-620, 1995.
7. KNOLL, J. YEN, T.T., and MIKLYA, I. Sexually low performing male rats die earlier than their high performing peers and (-)deprenyl treatment eliminates this difference. Life Sci. 54, 1047-1057, 1994.
8. KNOLL, J., KNOLL, B., and MIKLYA, I. High performing rats are more sensitive toward catecholaminergic activity enhancer (CAE) compounds than their low performing peers. Life Sci. 58, 945-952, 1996a.
9. KNOLL, J., MIKLYA, I., KNOLL, B., MARKO, R., and KELEMEN, K. (-)Deprenyl and (-)l-phenyl-2-propylaminopentane, [(-)PPAP], act primarily as potent stimulants of action potential-transmitter release coupling in the catecholaminergic neurons. Life Sci. 58, 817-827, 1996b.
10. KNOLL, J., MIKLYA, I. KNOLL, B. MARKÓ, R. and RÁCZ, D. Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain. Life Sci. 58, 2101-2114, 1996c.
11. KNOLLEMA, S., AUKEMA, W., HOM, H., KORF, J., and TER HORST, G.J. L. Deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia. Stroke 26, 1883-1887, 1995.
12. PARKINSON STUDY GROUP. Effect of (-)deprenyl on the progression disability in early Parkinson's disease. N. Engl. J. Med. 321, 1364-1371, 1989.
13. PARKINSON STUDY GROUP. Effect of tocopherol and (-)deprenyl on the progression of disability in early Parkinson's disease. N. Engl. J. Med. 328, 176-183, 1993.
14. SARANSAARI, P., SUHONEN, J., LILLRANK, S., and OJA, S.S. Effects of long-term treatment with a monoamine oxidase B inhibitor, selegiline (L-deprenyl), on amino acid transmitter systems in the ageing rat brain. Proc. West. Pharmacol. Soc. 38, 13-17, 1995.
15. TETRUD, J.W. and LANGSTON, J.W. The effect of (-)deprenyl (selegiline) on the natural history of Parkinson's disease. Science 245, 519-522, 1989.
16. YU, W.Y., HOLLAND, D.P., and TATTON, W.G. (-)-Deprenyl alters the time course of death of axotomized facial mononeurons and the hypertrophy of neighboring astrocytes in immature rats. Exp. Neurol. 126, 233-246, 1994.